Literature DB >> 6594171

Changes in surface antigens of HL-60 cells during differentiation in vitro.

J F San Miguel, D M McCarthy, B Rodriques, H C Freake, H Zola, J M Goldman, D Catovsky.   

Abstract

We have examined the pattern of binding of monoclonal antibodies OKM 1, FMC 10, FMC 12, FMC 13, FMC 17 and FMC 33 to human promyelocytic leukaemia (HL-60) cells. We found that the expression of antigens detectable with FMC 17 and FMC 33 (specific for monocytes and macrophages) was increased by exposure of HL-60 cells to 1,25-dihydroxyvitamin D3 but not by exposure of HL-60 cells to 12-tetradecanoyl phorbol-13-acetate (TPA). The antigen detected with the OKM 1 antibody was highly induced by TPA. The expression of granulocyte-specific antigens detected by FMC 10 and FMC 13 was increased during induction of granulocytic maturation; these antigens were retained during monocyte-macrophage differentiation of HL-60 cells. We conclude that in some cases the expression of particular antigens during maturation of malignant cells proceeds normally while in other cases antigenic differences between leukaemic and normal cells at equivalent levels of maturation can be detected.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6594171     DOI: 10.1007/bf00319884

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  13 in total

1.  Membrane antigens of human cells of the monocyte/macrophage lineage studied with monoclonal antibodies.

Authors:  D A Brooks; H Zola; P J McNamara; J Bradley; K F Bradstock; W W Hancock; R C Atkins
Journal:  Pathology       Date:  1983-01       Impact factor: 5.306

2.  1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells.

Authors:  D M McCarthy; J F San Miguel; H C Freake; P M Green; H Zola; D Catovsky; J M Goldman
Journal:  Leuk Res       Date:  1983       Impact factor: 3.156

3.  A monoclonal antibody reactive with human peripheral blood monocytes.

Authors:  J Breard; E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

4.  Terminal differentiation surface antigens of myelomonocytic cells are expressed in human promyelocytic leukemia cells (HL60) treated with chemical inducers.

Authors:  B Perussia; D Lebman; S H Ip; G Rovera; G Trinchieri
Journal:  Blood       Date:  1981-10       Impact factor: 22.113

5.  Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester.

Authors:  G Rovera; D Santoli; C Damsky
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

6.  Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia.

Authors:  R Gallagher; S Collins; J Trujillo; K McCredie; M Ahearn; S Tsai; R Metzgar; G Aulakh; R Ting; F Ruscetti; R Gallo
Journal:  Blood       Date:  1979-09       Impact factor: 22.113

7.  Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3.

Authors:  Z Bar-Shavit; S L Teitelbaum; P Reitsma; A Hall; L E Pegg; J Trial; A J Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

8.  1 alpha,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60).

Authors:  H Tanaka; E Abe; C Miyaura; T Kuribayashi; K Konno; Y Nishii; T Suda
Journal:  Biochem J       Date:  1982-06-15       Impact factor: 3.857

9.  Differentiation-linked expression of cell surface markers on HL-60 leukemic cells.

Authors:  M A Boss; D Delia; J B Robinson; M F Greaves
Journal:  Blood       Date:  1980-11       Impact factor: 22.113

10.  The expression of myeloid-specific antigens on myeloid leukemia cells: correlations with leukemia subclasses and implications for normal myeloid differentiation.

Authors:  E D Ball; M W Fanger
Journal:  Blood       Date:  1983-03       Impact factor: 22.113

View more
  1 in total

1.  Transforming growth factor-beta 1 modulates the effect of 1 alpha, 25-dihydroxyvitamin D3 on leukemic cells.

Authors:  M Morikawa; N Harada; G Soma; T Yoshida
Journal:  In Vitro Cell Dev Biol       Date:  1990-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.